Resource title

Evidence of comparative efficacy should have a formal role in European drug approvals

Resource image

image for OpenScout resource :: Evidence of comparative efficacy should have a formal role in European drug approvals

Resource description

Despite methodological concerns, comparative efficacy evidence should be required at the time of drug approval, says Corinna Sorenson and colleagues, to allow patients, clinicians, and other healthcare decision makers to determine whether a new drug is superior, equivalent, or inferior to its existing alternatives.

Resource author

Resource publisher

Resource publish date

Resource language

en

Resource content type

Resource resource URL

http://eprints.lse.ac.uk/38191/

Resource license